Home Applications 761034 Application 761034
Type BLA
Sponsor GENENTECH INC Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761034 Tecentriq atezolizumab 351(a) Rx 2026-07-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TECENTRIQ ATEZOLIZUMAB INJECTABLE;INJECTION 1200MG/20ML No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 33 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-917 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current 50242-918 TECENTRIQ atezolizumab Genentech, Inc. BLA Current